{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:47:47Z","timestamp":1787755667908,"version":"build-2784847793"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760698"],"award-info":[{"award-number":["81760698"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC0684"],"award-info":[{"award-number":["2025ZNSFSC0684"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018806","name":"Hubei Province Department of Science and Technology","doi-asserted-by":"publisher","award":["2025AFD091"],"award-info":[{"award-number":["2025AFD091"]}],"id":[{"id":"10.13039\/501100018806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jaut.2026.103553","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:33:23Z","timestamp":1775129603000},"page":"103553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Divergent safety profiles of TNF inhibitors in pregnancy: a comprehensive pharmacovigilance analysis of the FAERS database"],"prefix":"10.1016","volume":"160","author":[{"given":"Zijun","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3649-2428","authenticated-orcid":false,"given":"Chenning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2026.103553_bib1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2026.103553_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2026.103553_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2026.103553_bib4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2026.103553_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2019.11.004","article-title":"Pregnancy and autoimmune diseases","volume":"64","author":"Somers","year":"2020","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.jaut.2026.103553_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s43556-021-00038-z","article-title":"Targeting regulatory T cells for immunotherapy in melanoma","volume":"2","author":"Huang","year":"2021","journal-title":"Mol Biomed"},{"key":"10.1016\/j.jaut.2026.103553_bib7","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2665-9913(25)00039-6","article-title":"Trends in the prevalence of autoimmune diseases during pregnancy in the UK, 2000\u201321: a retrospective cohort study","volume":"7","author":"Singh","year":"2025","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.jaut.2026.103553_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41584-019-0240-8","article-title":"Stratifying management of rheumatic disease for pregnancy and breastfeeding","volume":"15","author":"Giles","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103553_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12916-024-03550-5","article-title":"Pregnancy complications and autoimmune diseases in women: systematic review and meta-analysis","volume":"22","author":"Singh","year":"2024","journal-title":"BMC Med."},{"issue":"25","key":"10.1016\/j.jaut.2026.103553_bib10","first-page":"S0002","article-title":"Hydroxychloroquine in systemic lupus erythematosus, Anti-SSA\/SSB, and antiphospholipid antibody-positive pregnancies","author":"Saleh","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jaut.2026.103553_bib11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103553_bib12","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/rheumatology\/kev404","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding\u2014Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids: table 1","volume":"55","author":"Flint","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2026.103553_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2026.103553_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","article-title":"Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection","volume":"151","author":"Julsgaard","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2026.103553_bib15","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1136\/annrheumdis-2017-211384","article-title":"Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study","volume":"76","author":"Clowse","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103553_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cpt.1827","article-title":"Assessment of placental disposition of Infliximab and etanercept in women with autoimmune diseases and in the Ex vivo perfused placenta","volume":"108","author":"Eliesen","year":"2020","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.jaut.2026.103553_bib17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/ecco-jcc\/jjaa225","article-title":"The influence of disease activity on pregnancy outcomes in women with inflammatory bowel disease: a systematic review and meta-analysis","volume":"15","author":"Kim","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.jaut.2026.103553_bib18","first-page":"2922","article-title":"The role of TNF-\u03b1 and Anti-TNF-\u03b1 agents during preconception","volume":"22","author":"Romanowska-Pr\u00f3chnicka","year":"2021","journal-title":"Pregnancy, and Breastfeeding, IJMS"},{"key":"10.1016\/j.jaut.2026.103553_bib19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ard.2025.02.012","article-title":"Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial","volume":"84","author":"Branch","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103553_bib20","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1017\/erm.2022.18","article-title":"TNF-\u03b1\/anti-TNF-\u03b1drugs and its effect on pregnancy outcomes","volume":"24","author":"Dai","year":"2022","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.jaut.2026.103553_bib21","article-title":"Safety of biologics in patients with autoimmune rheumatic diseases during pregnancy: systematic review and meta-analysis","volume":"24","author":"Li","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2026.103553_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.3701","article-title":"FDA adverse event reporting system (FAERS) essentials: a guide to understanding, applying, and interpreting adverse event data reported to FAERS","author":"Potter","year":"2025","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.jaut.2026.103553_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40264-024-01421-9","article-title":"The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in pharmacovigilance (READUS-PV): development and statement","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf."},{"key":"10.1016\/j.jaut.2026.103553_bib24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40264-024-01423-7","article-title":"The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in pharmacovigilance (READUS-PV): explanation and elaboration","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf."},{"key":"10.1016\/j.jaut.2026.103553_bib25","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2026.103553_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidemiology and Drug"},{"key":"10.1016\/j.jaut.2026.103553_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiology and Drug"},{"key":"10.1016\/j.jaut.2026.103553_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A bayesian neural network method for adverse drug reaction signal generation","volume":"54","author":"Bate","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jaut.2026.103553_bib29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf."},{"key":"10.1016\/j.jaut.2026.103553_bib30","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. Roy. Soc. Med."},{"key":"10.1016\/j.jaut.2026.103553_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13643-020-01426-2","article-title":"Assessment of causal link between psychological factors and symptom exacerbation in inflammatory bowel disease: a systematic review utilising Bradford hill criteria and meta-analysis of prospective cohort studies","volume":"9","author":"Schoultz","year":"2020","journal-title":"Syst. Rev."},{"key":"10.1016\/j.jaut.2026.103553_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cpt.2920","article-title":"Tumor lysis syndrome associated with monoclonal antibodies in patients with multiple myeloma: a pharmacovigilance study based on the FAERS database","volume":"114","author":"Xia","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2026.103553_bib33","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/pds.4790","article-title":"Time to onset in statistical signal detection revisited: a follow\u2010up study in long\u2010term onset adverse drug reactions","volume":"28","author":"Scholl","year":"2019","journal-title":"Pharmacoepidemiology and Drug"},{"key":"10.1016\/j.jaut.2026.103553_bib34","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s40264-013-0061-7","article-title":"Illustration of the weibull shape parameter signal detection tool using electronic healthcare record data","volume":"36","author":"Sauzet","year":"2013","journal-title":"Drug Saf."},{"key":"10.1016\/j.jaut.2026.103553_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575197","article-title":"Maternal immunological adaptation during normal pregnancy","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103553_bib36","article-title":"Regulation of the JAK2-STAT5 pathway by signaling molecules in the mammary gland","volume":"8","author":"Hajjo","year":"2002","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jaut.2026.103553_bib37","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1186\/s12885-020-07228-y","article-title":"The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages","volume":"20","author":"Shirmohammadi","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jaut.2026.103553_bib38","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ymthe.2024.12.011","article-title":"In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors","volume":"33","author":"Kang","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jaut.2026.103553_bib39","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamaneurol.2020.1162","article-title":"Association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events","volume":"77","author":"Kunchok","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2026.103553_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/20552173211070750","article-title":"Central nervous system demyelination related to tumour necrosis factor alpha inhibitor","volume":"8","author":"Chey","year":"2022","journal-title":"Multiple Sclerosis Journal - Experimental, Translational and Clinical"},{"key":"10.1016\/j.jaut.2026.103553_bib41","article-title":"Pharmacologic inhibition of reactive gliosis blocks TNF-\u03b1-mediated neuronal apoptosis","volume":"7","author":"Johansen","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jaut.2026.103553_bib42","article-title":"The use and safety of TNF inhibitors during pregnancy in women with psoriasis","volume":"19","author":"Johansen","year":"2018","journal-title":"A Review, IJMS"},{"key":"10.1016\/j.jaut.2026.103553_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2024-301252","article-title":"Elucidating the bidirectional association between autoimmune diseases and depression: a systematic review and meta-analysis","volume":"27","author":"Li","year":"2024","journal-title":"BMJ Ment Health"},{"key":"10.1016\/j.jaut.2026.103553_bib44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41398-020-00873-8","article-title":"An independent component analysis reveals brain structural networks related to TNF-\u03b1 in drug-na\u00efve, first-episode major depressive disorder: a source-based morphometric study","volume":"10","author":"Kakeda","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jaut.2026.103553_bib45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.abd.2021.07.002","article-title":"Case for diagnosis. Pregnant woman in the 3rd trimester with pruritic papules and pustules on the trunk. Pruritic folliculitis of pregnancy","volume":"97","author":"Amorim","year":"2022","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.jaut.2026.103553_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/7567708","article-title":"Understanding the immune system in fetal protection and maternal infections during pregnancy","volume":"2022","author":"Hussain","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jaut.2026.103553_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113800","article-title":"Maternal aspartame exposure alters lung Th1\/Th2 cytokine balance in offspring through nuclear factor-\u03baB activation","volume":"145","author":"Chuang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jaut.2026.103553_bib48","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.42948","article-title":"Characterization of a novel pathogenic <scp>PLCG2<\/scp> variant leading to APLAID syndrome responsive to a TNF inhibitor","volume":"76","author":"Yang","year":"2024","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2026.103553_bib49","article-title":"Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019","volume":"22","author":"Cao","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2026.103553_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103259","article-title":"Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th international conference on reproduction, pregnancy and rheumatic diseases","volume":"22","author":"Andreoli","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2026.103553_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2288-14-17","article-title":"Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases","volume":"14","author":"Leroy","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jaut.2026.103553_bib52","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","article-title":"EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update","volume":"84","author":"R\u00fcegg","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103553_bib53","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMra1614676","article-title":"Fertility preservation in women","volume":"377","author":"Donnez","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2026.103553_bib54","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/ibd\/izab206","article-title":"Risk factors for postpartum disease activity in women with inflammatory bowel disease: a systematic review and meta-analysis","volume":"28","author":"Malhi","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jaut.2026.103553_bib55","doi-asserted-by":"crossref","first-page":"491","DOI":"10.14309\/ajg.0000000000002179","article-title":"Maternal inflammatory bowel disease during pregnancy and infectious disease in offspring younger than 5 years: a population-based cohort study","volume":"118","author":"Ren","year":"2023","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2026.103553_bib56","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.4044","article-title":"Association of prenatal care services, maternal morbidity, and perinatal mortality with the advanced maternal age cutoff of 35 years","volume":"2","author":"Geiger","year":"2021","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.jaut.2026.103553_bib57","doi-asserted-by":"crossref","DOI":"10.1007\/s40264-025-01643-5","article-title":"Unveiling the limits of anticholinergic burden scales: a study of adverse drug reactions in the French pharmacovigilance database","author":"Pecquet","year":"2026","journal-title":"Drug Saf."},{"key":"10.1016\/j.jaut.2026.103553_bib58","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40264-024-01433-5","article-title":"Comparators in pharmacovigilance: a quasi-quantification bias analysis","volume":"47","author":"Gravel","year":"2024","journal-title":"Drug Saf."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:42:59Z","timestamp":1777333379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841126000314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":58,"alternative-id":["S0896841126000314"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103553","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Divergent safety profiles of TNF inhibitors in pregnancy: a comprehensive pharmacovigilance analysis of the FAERS database","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103553"}}